What is a low voltage complex on an electrocardiogram (ECG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Low Voltage Complex on ECG: Definition and Clinical Significance

Low voltage on ECG is defined as QRS amplitude <0.5 mV (5 mm) in all limb leads AND/OR <1.0 mV (10 mm) in all precordial leads, and represents a critical warning sign demanding immediate echocardiography to identify life-threatening conditions including cardiac amyloidosis, pericardial effusion with tamponade, and dilated cardiomyopathy. 1, 2

Diagnostic Criteria

Low voltage can be assessed using three distinct methods, each with different prevalence rates and clinical implications:

  • Limb lead criteria (L-LQRSV): QRS amplitude ≤0.5 mV in all limb leads—this is the most common pattern, accounting for 81.4% of low voltage cases 3
  • Precordial lead criteria (P-LQRSV): QRS amplitude ≤1.0 mV in all precordial leads—accounts for 12.3% of cases 3
  • Combined criteria (C-LQRSV): Both limb and precordial criteria met simultaneously—the rarest pattern at 6.4% but carries the highest risk with 12.41% in-hospital mortality 3
  • Sokolow index: ≤1.5 mV is independently associated with adverse outcomes (HR 1.690, p=0.0246) and has the highest prevalence among cardiac amyloidosis patients at 60% 4

Life-Threatening Differential Diagnosis

Cardiac Amyloidosis

Low voltage despite increased left ventricular wall thickness on echocardiography is pathognomonic for cardiac amyloidosis. 5, 1 This voltage-to-mass discordance is the key diagnostic finding:

  • Reduced QRS voltage occurs in approximately 50% of cardiac amyloidosis patients despite ventricular wall thickening 5
  • The ratio of QRS voltage to LV wall thickness is diagnostically valuable 1
  • Cardiac amyloidosis shows 49.4% prevalence of low voltage, the highest among all cardiomyopathies 3
  • Low voltage is a relatively late finding and may not be useful for early identification 4

Pericardial Effusion/Tamponade

  • Pericardial effusion can present with low voltage as the initial ECG finding and requires immediate echocardiography to assess for hemodynamic compromise 1, 6
  • The mechanism involves increased distance between the heart and recording electrodes due to fluid accumulation 7

Dilated Cardiomyopathy

  • Among patients with low voltage isolated to limb leads (voltage discordance), 63% have dilated ventricles with average ejection fraction of 33% 2
  • Low voltage in this context reflects reduced myocardial mass or altered electrical properties 2

Other Critical Causes

  • Arrhythmogenic cardiomyopathy: 31.2% prevalence of low voltage 3
  • Takotsubo syndrome: 25.7% prevalence of low voltage 3
  • Myocarditis and sarcoidosis: Can present with low voltage and conduction abnormalities 1

Extracardiac Causes

Low voltage can result from influences of the passive body volume conductor rather than cardiac pathology:

  • Chronic obstructive pulmonary disease: Low diaphragm position causes V3 and V4 to be located above ventricular boundaries, recording negative deflections 5
  • Obesity: Increased tissue impedance attenuates QRS voltage 5
  • Peripheral edema: Any etiology induces reversible low voltage and reduces P wave and T wave amplitudes 7
  • Pleural effusion: Increases distance between heart and chest wall electrodes 7

Technical Causes (Must Exclude First)

Electrode misplacement is the most frequent cause of apparent low voltage and must be excluded before pursuing extensive workup. 8, 9

  • Superior displacement of V1 and V2 electrodes reduces R-wave amplitude by approximately 0.1 mV per interspace 5, 9
  • Inferior placement of V5 and V6 in the sixth intercostal space alters amplitudes used in ventricular hypertrophy diagnosis 5
  • Precordial lead misplacement explains considerable variability in amplitude measurements between serial tracings 5
  • Placement of precordial electrodes in women with large breasts remains problematic and affects voltage measurements 5

Mandatory Evaluation Algorithm

Step 1: Verify Technical Accuracy

  • Repeat ECG with meticulous attention to electrode placement, ensuring V1 and V2 are in the fourth intercostal space at sternal borders 5, 8
  • Ensure V5 and V6 follow the horizontal plane of V4 rather than the fifth intercostal space 5

Step 2: Immediate Echocardiography

Echocardiography is the mandatory first test and must be obtained urgently. 1

  • Assess LV systolic function, wall thickness, and presence of pericardial effusion 1
  • Calculate wall thickness-to-voltage ratio: Low voltage with increased wall thickness strongly suggests amyloidosis 1
  • Evaluate for dilated cardiomyopathy, particularly if voltage discordance (low limb voltage with normal precordial voltage) is present 2

Step 3: Advanced Imaging Based on Initial Findings

  • Cardiac MRI with late gadolinium enhancement: Recommended if echocardiogram shows structural abnormalities, especially for tissue characterization in suspected infiltrative disease 1
  • Subendocardial late gadolinium enhancement globally suggests cardiac amyloid involvement 5
  • Combined low voltage (C-LQRSV) patients show higher prevalence of myocardial fibrosis on CMR compared to isolated patterns 3

Step 4: Additional Testing

  • 24-48 hour ambulatory ECG monitoring if conduction abnormalities are present 1
  • BNP levels: Elevated in 93% sensitivity and 90% specificity for cardiac amyloidosis involvement, even without clinical heart failure 5
  • Consider endomyocardial biopsy if diagnosis remains uncertain after extensive non-invasive testing 5

Prognostic Significance

Combined low voltage (C-LQRSV) confers the highest risk with an odds ratio of 8.63 for in-hospital death or discharge against medical advice. 3

  • Overall LQRSV is an independent predictor of adverse outcomes (OR 3.27,95% CI 2.94-3.64) 3
  • Sokolow index ≤1.5 mV independently predicts hospitalization, transplant, and death (HR 1.690) 4
  • C-LQRSV patients exhibit worse echocardiographic parameters compared to isolated patterns or normal voltage 3

Critical Pitfalls to Avoid

  • Never dismiss low voltage as benign without echocardiography: Even in asymptomatic patients, underlying structural disease may be present 1, 6
  • Do not rely on low voltage alone for diagnosis: Only 50% of cardiac amyloidosis patients demonstrate this finding 5
  • Recognize voltage discordance: Low voltage isolated to limb leads correlates with dilated cardiomyopathy in >60% of cases without other associated conditions 2
  • Consider clinical context: Age, cardiac risk factors, symptoms, and family history modify interpretation 9
  • Peripheral edema alters measurements: Any edema etiology induces reversible low voltage with enormous clinical implications 7

References

Guideline

Low Voltage ECG Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

ECGs with small QRS voltages.

Singapore medical journal, 2012

Research

Low QRS voltage and its causes.

Journal of electrocardiology, 2008

Guideline

Management and Treatment of Abnormal R Wave Progression

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Poor R-Wave Progression: Clinical Significance and Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.